PlainPharmaWatch

CMS Open Payments · Program Year 2024

CorMedix Inc.

CorMedix Inc. reported $120,248.72 across General Payments, Research, and Ownership to 1,060 physicians and teaching hospitals across 1,060 transactions.

See the rankings → How this is sourced
$120.2K
All-tracks total
1,060
Transactions
1,060
Recipients
#1134
of 1,925 companies

CorMedix Inc. reported $120,248.72 across all CMS Open Payments tracks (General + Research + Ownership) to 1,060 physicians and teaching hospitals in Program Year 2024 - ranking #1134 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $120,248.72, averaging $113.44 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer cormedix-inc CorMedix Inc.

$120.2K · #1134/1,925 · 0.0% industry · PY2024

  • TOT $120.2K
  • RANK #1134
  • SHARE 0.0%
  • TXN 1,060
  • RCP 1,060
  • CAT 3
  • GEN $120.2K
  • TOP1 33.2%
  • PY 2024

Volume peers

Nearest volume peer: Aurobindo Pharma USA, Inc. ($120.1K)

Shalby Advanced Technologies…$120.5KCorMedix Inc. (this)$120.2KAurobindo Pharma USA, Inc.$120.1KNovartis Gene Therapies, Inc…$120.0KNuMED for Children, LLC$120.0K
All-tracks payment totals near CorMedix Inc. (CMS Open Payments PY2024)

CorMedix Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for CorMedix Inc.

Rank #1134 of 1,925 companies in CMS Open Payments for 2024 belongs to CorMedix Inc., which reported $120,248.72 across 1,060 transactions to 1,060 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $113.44 per transaction and $113.44 per recipient.

The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $86.5K, accounting for 71.9% of this company's General Payments and 9 transactions.

General Payment Breakdown by Type

Across 3 types of general payments, CorMedix Inc.'s largest category was "Consulting Fee" at $86.5K - 71.9% of General Payments.

How CorMedix Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$86.5K2. Food and Beverage$30.7K3. Travel and Lodging$3.0K
Payment Type Amount Transactions
Consulting Fee $86.5K 9
Food and Beverage $30.7K 1,045
Travel and Lodging $3.0K 6

Recipient Concentration in General Payments

The five largest recipient relationships account for $90,482.60 (75.2%) of $120,248.72 in this company's General Payments records across 739 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for CorMedix Inc.

The five named recipients with the highest reported General Payments from this company

Alan William Dunton$39.9KJanet Connor$39.0KAnil K Agarwal$10.3KBruce Reidenberg$812.50Payal Patel$446.78
  1. 1

    Alan William Dunton

    $39,873.32 across 11 reported transactions

  2. 2

    Janet Connor

    $39,000.00 across 2 reported transactions

  3. 3

    Anil K Agarwal

    $10,350.00 across 1 reported transactions

  4. 4

    Bruce Reidenberg

    $812.50 across 3 reported transactions

  5. 5

    Payal Patel

    $446.78 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as CorMedix Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about CorMedix Inc..

Catalyst OrthoScience

HHI 2229

Peter Brasseler Holdings, LLC

HHI 2223

Paragonix Technologies, Inc.

HHI 2220

Freudenberg Medical, LLC

HHI 2216

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with CorMedix Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download CorMedix Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.